Dry eye diagnosis and management in 2004

Current Opinion in Ophthalmology

Volumn 15, Issue 4, 2004, Pages 299-304

  Perry, Henry D ^a,c   Donnenfeld, Eric D ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Cyclosporine a; Dry eye disease; Immunomodulation; Restasis

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; DYE; FLUORESCEIN; GELATINASE B; IMMUNOMODULATING AGENT; ROSE BENGAL;

AQUEOUS HUMOR; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG APPROVAL; DRY EYE; ENZYME ACTIVITY; EVAPORATION; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; KERATOCONJUNCTIVITIS SICCA; MEIBOMIAN GLAND; PATHOGENESIS; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SCHIRMER TEST; STAINING; TEAR FILM;

DRY EYE SYNDROMES; HUMANS; OPHTHALMOLOGY;

EID: 3242656166     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200408000-00004     Document Type: Review

References (24)

1. Schaumberg DA, Sullivan DA, Buring JE, et al.: Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003, 136:318-326. Large and best comprehensive study underlining the number of patients with dry eye disease and its common occurrence, especially in postmenopausal women.
2. Fox RI, Howell FV, Bone RC, et al.: Primary Sjögren's syndrome: clinical and immunopathologic features. Semin Arthritis Rheumatol 1984, 14:77-105.
3. Lin PY, Tsai SY, Cheng CY, et al.: Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 2003, 110:1096-1101. First large comprehensive study documenting the incidence of dry eye disease in Asians. Also documents the incidence of signs and symptoms approaching 33% (higher than previous large studies) in this population.
4. Schein OD, Tielsch JM, Munoz B, et al.: Relation between signs and symptoms of dry eye in the elderly: a population-based perspective. Ophthalmology 1997, 104:1395-1401.
5. Afonso A, Monroy D, Stern ME, et al.: Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology 1999, 106:803-810.
6. Macri A, Pflugfelder S: Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease. Arch Ophthalmol 2000, 118:1632-1638.
7. Chodosh J, Dix RD, Howell RC, et al.: Staining characteristics and antiviral activities of sulforhodamine B and lissamine green. Invest Ophthalmol Vis Sci 1994, 35:1046-1058.
8. Feenstra RP, Tseng SC: Comparison of fluorescein and rose Bengal staining. Ophthalmology 1992, 99:605-617.
9. Kim J, Foulks GN: Evaluation of the effect of lissamine green and rose bengal on human corneal epithelial cells. Cornea 1999, 183:328-332.
10. Manning FJ, Wehrly SR, Foulks GN: Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal. Ophthalmology 1995, 102:1953-1957.
11. Lemp MA: Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J 1995, 21:221-232.
12. Huang B, Mirza MA, Qazi MA, et al.: The effect of punctal occlusion on wavefront aberrations in dry eye patients after laser in situ keratomileusis. Am J Ophthalmol 2004, 137:52-61. First study documenting the effect of punctal occlusion decreasing the wave front aberrations in patients with dry eye disease. This study also shows how wave front technology can screen for dry eye abnormalities.
13. Sade De Paiva C, Pflugfelder SC: Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation. Am J Ophthalmol 2004, 137:109-115. This study firmly documents the profound anesthesia resulting from LASIK procedures and points out reasons for symptoms related to induced dry eye disease.
14. Pflugfelder SC, Jones D, Ji Z, et al.: Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999, 19:201-211.
15. Song XJ, Li DQ, Farley W, et al.: Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 2003, 44:4223-4229.
16. Prabhasawat P, Tseng SC: Frequent association of delayed tear clearance in ocular irritation. Br J Ophthalmol 1998, 82:666-675.
17. Marsh P, Pflugfelder SC: Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren's syndrome. Ophthalmology 1999, 106:811-816.
18. Small DS, Acheampong A, Reis B, et al.: Blood concentrations of cyclosporin a during long-term treatment with cyclosporin a ophthalmic emulsions in patients with moderate to severe dry eye disease. J Ocul Pharmacol Ther 2002, 18:411.
19. Kunert KS, Tisdale AS, Gipson IK: Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine 2. Arch Ophthalmol 2002, 120:330-337. This study uses histopathologic techniques to correlate the effects of topical cyclosporine A on restoring the normal goblet cell count in patients with severe dry eye disease after a 6-month treatment course.
20. Hori Y, Spurr-Michaud S, Russo CL, et al. Differential regulation of membrane-associated mucins in the human ocular surface epithelium. Invest Ophthalmol Vis Sci 2004, 45:112-117. This interesting article shows that autologous serum and retinoic acid are helpful in upregulating mucin production in human ocular surface epithelium. These data also suggest that P2Y2 type inhibitors may become useful adjuncts in the treatment of dry eye disease.
21. Perry HD, Doshi S, Donnenfeld ED, et al.: Double masked randomized controlled study evaluating topical 0.05[ref] cyclosporine A in the treatment of meibomian gland dysfunction (posterior blepharitis). Invest Ophthalmol Vis Sci 2003;44:E. This study provides the first evidence that Restasis (topical 0.05% cyclosporine A) may be effective in treating patients with meibomian gland dysfunction, probably the most common cause of dry eye disease.
22. Jumblatt JE, Jumblatt MM: Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva. Exp Eye Res 1998, 67:341-346.
23. Rocha EM, Wickham LA, da Silveira LA, et al.: Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol 2000, 84:76-84.
24. Cermak JM, Krenzer KL, Sullivan RM, et al.: Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? Cornea 2003, 22:516-521. Convincing study showing the prominence of androgens in the regulation of tear flow, especially the lipid component. The authors suggest and show evidence that topical testosterone may be helpful in treating patients with meibomian gland dysfunction and Sjogren syndrome.